Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 109

Similar articles for PubMed (Select 23552325)

1.

Chlorthalidone versus hydrochlorothiazide for the treatment of hypertension in older adults: a population-based cohort study.

Dhalla IA, Gomes T, Yao Z, Nagge J, Persaud N, Hellings C, Mamdani MM, Juurlink DN.

Ann Intern Med. 2013 Mar 19;158(6):447-55. doi: 10.7326/0003-4819-158-6-201303190-00004.

PMID:
23552325
2.

Evaluation of the efficacy and safety of a hydrochlorothiazide to chlorthalidone medication change in veterans with hypertension.

Matthews KA, Brenner MJ, Brenner AC.

Clin Ther. 2013 Sep;35(9):1423-30. doi: 10.1016/j.clinthera.2013.07.430. Epub 2013 Aug 29.

PMID:
23993697
3.

Chlorthalidone reduces cardiovascular events compared with hydrochlorothiazide: a retrospective cohort analysis.

Dorsch MP, Gillespie BW, Erickson SR, Bleske BE, Weder AB.

Hypertension. 2011 Apr;57(4):689-94. doi: 10.1161/HYPERTENSIONAHA.110.161505. Epub 2011 Mar 7.

4.

Risk of hyponatremia with diuretics: chlorthalidone versus hydrochlorothiazide.

van Blijderveen JC, Straus SM, Rodenburg EM, Zietse R, Stricker BH, Sturkenboom MC, Verhamme KM.

Am J Med. 2014 Aug;127(8):763-71. doi: 10.1016/j.amjmed.2014.04.014. Epub 2014 May 5.

PMID:
24811554
5.

Long-term renal and cardiovascular outcomes in Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) participants by baseline estimated GFR.

Rahman M, Ford CE, Cutler JA, Davis BR, Piller LB, Whelton PK, Wright JT Jr, Barzilay JI, Brown CD, Colon PJ Sr, Fine LJ, Grimm RH Jr, Gupta AK, Baimbridge C, Haywood LJ, Henriquez MA, Ilamaythi E, Oparil S, Preston R; ALLHAT Collaborative Research Group.

Clin J Am Soc Nephrol. 2012 Jun;7(6):989-1002. doi: 10.2215/CJN.07800811. Epub 2012 Apr 5.

6.

Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure.

Ernst ME, Carter BL, Goerdt CJ, Steffensmeier JJ, Phillips BB, Zimmerman MB, Bergus GR.

Hypertension. 2006 Mar;47(3):352-8. Epub 2006 Jan 23.

7.

Clinical significance of incident hypokalemia and hyperkalemia in treated hypertensive patients in the antihypertensive and lipid-lowering treatment to prevent heart attack trial.

Alderman MH, Piller LB, Ford CE, Probstfield JL, Oparil S, Cushman WC, Einhorn PT, Franklin SS, Papademetriou V, Ong ST, Eckfeldt JH, Furberg CD, Calhoun DA, Davis BR; Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group.

Hypertension. 2012 May;59(5):926-33. doi: 10.1161/HYPERTENSIONAHA.111.180554. Epub 2012 Mar 19.

8.

Antihypertensive efficacy of hydrochlorothiazide vs chlorthalidone combined with azilsartan medoxomil.

Bakris GL, Sica D, White WB, Cushman WC, Weber MA, Handley A, Song E, Kupfer S.

Am J Med. 2012 Dec;125(12):1229.e1-1229.e10. doi: 10.1016/j.amjmed.2012.05.023. Epub 2012 Aug 30.

PMID:
22939358
9.

Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Barzilay JI, Davis BR, Cutler JA, Pressel SL, Whelton PK, Basile J, Margolis KL, Ong ST, Sadler LS, Summerson J; ALLHAT Collaborative Research Group.

Arch Intern Med. 2006 Nov 13;166(20):2191-201.

PMID:
17101936
10.

Hydrochlorothiazide versus chlorthalidone in the management of hypertension.

Neff KM, Nawarskas JJ.

Cardiol Rev. 2010 Jan-Feb;18(1):51-6. doi: 10.1097/CRD.0b013e3181c61b52. Review.

PMID:
20010338
11.

Cardiovascular outcomes in high-risk hypertensive patients stratified by baseline glomerular filtration rate.

Rahman M, Pressel S, Davis BR, Nwachuku C, Wright JT Jr, Whelton PK, Barzilay J, Batuman V, Eckfeldt JH, Farber MA, Franklin S, Henriquez M, Kopyt N, Louis GT, Saklayen M, Stanford C, Walworth C, Ward H, Wiegmann T; ALLHAT Collaborative Research Group.

Ann Intern Med. 2006 Feb 7;144(3):172-80.

PMID:
16461961
12.

[Chlorthalidone better than hydrochlorothiazide in hypertension].

Kooter AJ, Smulders YM.

Ned Tijdschr Geneeskd. 2010;154:A1608. Dutch.

PMID:
20456766
13.
14.

The comparative effectiveness of hydrochlorothiazide and chlorthalidone in an observational cohort of veterans.

Lund BC, Ernst ME.

J Clin Hypertens (Greenwich). 2012 Sep;14(9):623-9. doi: 10.1111/j.1751-7176.2012.00679.x.

PMID:
22947361
15.

Hydrochlorothiazide versus chlorthalidone: evidence supporting their interchangeability.

Carter BL, Ernst ME, Cohen JD.

Hypertension. 2004 Jan;43(1):4-9. Epub 2003 Nov 24. Review.

16.

Clinical inquiry: How do hydrochlorothiazide and chlorthalidone compare for treating hypertension?

Kildare L, Jones T, Neher JO, St Anna L.

J Fam Pract. 2014 Apr;63(4):227-8. Review. No abstract available.

PMID:
24905126
17.

Association between chlorthalidone treatment of systolic hypertension and long-term survival.

Kostis JB, Cabrera J, Cheng JQ, Cosgrove NM, Deng Y, Pressel SL, Davis BR.

JAMA. 2011 Dec 21;306(23):2588-93. doi: 10.1001/jama.2011.1821.

PMID:
22187278
18.

Chlorthalidone compared with hydrochlorothiazide in reducing cardiovascular events: systematic review and network meta-analyses.

Roush GC, Holford TR, Guddati AK.

Hypertension. 2012 Jun;59(6):1110-7. doi: 10.1161/HYPERTENSIONAHA.112.191106. Epub 2012 Apr 23. Review.

20.

A comparison of chlorthalidone-reserpine and hydrochlorothiazide-methyldopa as step 2 therapy for hypertension.

Channick BJ, Kessler WB, Marks AD, Adlin EV.

Clin Ther. 1981;4(3):175-83.

PMID:
7307035
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk